-
Posted by
Two Blokes May 23 -
Filed in
General
-
#TwoBlokesTrading
-
2 views
Global private equity and venture capital investments in pharmaceutical companies lag 2024 figures, and regulatory headwinds are tempering further activity. Private equity deal value in the pharmaceutical sector reached $7.9 billion across 53 deals from Jan. 1 to May 9, less than half the $20.44 billion from 101 deals in the first five months of 2024, according to S&P Global Market Intelligence data.
